Lincoln National Corp’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Lincoln National Corp’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,922	Closed	-$204K	–	894
2022 Q1	$204K	Sell	5,922 -8,176	-58%	-$289K	﹤0.01%	862
2021 Q4	$618K	Sell	14,098 -922	-6%	-$43.6K	0.01%	458
2021 Q3	$762K	Sell	15,020 -201	-1%	-$10.5K	0.02%	388
2021 Q2	$792K	Sell	15,221 -2,286	-13%	-$107K	0.02%	370
2021 Q1	$800K	Buy	17,507 +500	+3%	+$24.4K	0.02%	336
2020 Q4	$781K	Buy	17,007 +1,125	+7%	+$48.6K	0.02%	323
2020 Q3	$619K	Buy	+15,882	New	+$611K	0.02%	338

Other funds holding IDNA

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

Lincoln National Corp's IDNA Position: Q2 2022 in Review

Lincoln National Corp sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q2 2022, closing a stake of 5,922 shares — an estimated $204K sold.

Lincoln National Corp first reported a position in IDNA in Q3 2020 and held it in 7 quarters. The position peaked at $800K in Q1 2021. 73 funds tracked by Wall St. Rank hold IDNA as of Q2 2022.

Lincoln National Corp reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q2 2022 after selling out during the quarter.
Lincoln National Corp sold 5,922 iShares Genomics Immunology and Healthcare ETF shares in Q2 2022, an estimated $204K.
Lincoln National Corp first reported a position in iShares Genomics Immunology and Healthcare ETF in Q3 2020 and held it in 7 quarters.
Lincoln National Corp's iShares Genomics Immunology and Healthcare ETF position peaked at $800K in Q1 2021.
73 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2022.

Based on Lincoln National Corp's 13F filing for Q2 2022, filed 2 Aug 2022.